Influence of obesity on the course, treatment and prognosis of chronic obstructive pulmonary disease

Cover Page


Cite item

Full Text

Abstract

Obesity is associated with many chronic diseases, including the cardiovascular system diseases, diabetes mellitus, and currently more and more attention is focused on the role of overweight and obesity in lung diseases. Chronic obstructive pulmonary disease is one of the diseases characterized by high incidence, disability, ranking third among the leading causes of death worldwide. Association between obesity and chronic obstructive pulmonary disease is increasingly recognized, but to date remains largely unexplored. On the one hand, the obesity is associated with reduced lung function, increasing prevalence of certain lung diseases. On the other hand, obesity has a protective effect in case of severe course of chronic obstructive pulmonary disease. The nature of nutrient intake and diet is also associated with lung function, which is reflected in the character of the course and progression of chronic obstructive pulmonary disease. Thus, the establishment and in-depth study of the causal relationships between obesity, nature of nutrition and lung function with a view to the further development of strategies for the prevention and treatment of chronic obstructive pulmonary disease in patients who are overweight or obese is relevant. Studying prognostic role of obesity in patients with chronic obstructive pulmonary disease is promising.

About the authors

S A Kozhevnikova

Voronezh State Medical University named after N.N. Burdenko

Author for correspondence.
Email: kozhevnikova_s_a@mail.ru

A V Budnevskiy

Voronezh State Medical University named after N.N. Burdenko

Email: kozhevnikova_s_a@mail.ru

E Ju Malysh

Voronezh State Medical University named after N.N. Burdenko

Email: kozhevnikova_s_a@mail.ru

E S Ovsyannikov

Voronezh State Medical University named after N.N. Burdenko

Email: kozhevnikova_s_a@mail.ru

References

  1. Agusti A., Edwards L.D., Rennard S.I. et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7 (5): 374-383. http://dx.doi.org/10.1371/journal.pone.0037483
  2. Bentley A.R., Kritchevsky S.B., Harris T.B. et al. Dietary antioxidants and FEV1 decline: the health, aging and body composition study. Eur. Respir. J. 2012; 39 (4): 979-984. http://dx.doi.org/10.1183/09031936.00190010
  3. Borel J.C., Tamisier R., Gonzalez-Bermejo J. et al. Noninvasive ventilation in mild obesity hypoventilation syndrome: a randomized controlled trial. Chest. 2012; 141 (3): 692-702. http://dx.doi.org/10.1378/chest.10-2531
  4. Bottai M., Pistelli F., Di Pede F. et al. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur. Respir. J. 2012; 20 (3): 665-673. http://dx.doi.org/10.1183/09031936.02.01282001
  5. Breyer M.K., Spruit M.A., Celis A.P. et al. Highly elevated C-reactive protein levels in obese patients with COPD: a fat chance? Clin. Nutr. 2009; 28 (6): 642-647. http://dx.doi.org/10.1016/j.clnu.2009.05.005
  6. Cao C., Wang R., Wang J. et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One. 2012; 7 (8): 488-492. http://dx.doi.org/10.1371/journal.pone.0043892
  7. Chailleux E., Laaban J.P., Veale D. Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest. 2013; 123 (5): 1460-1466. http://dx.doi.org/10.1378/chest.123.5.1460
  8. Chen Y., Rennie D., Cormier Y.F., Dosman J. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am. J. Clin. Nutr. 2007; 85 (1): 35-39.
  9. De Batlle J., Barreiro E., Romieu I. et al. Dietary modulation of oxidative stress in chronic obstructive pulmonary disease patients. Free Radic. Res. 2010; 44 (11): 1296-1303. http://dx.doi.org/10.3109/10715762.2010.500667
  10. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between COPD and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2014; 59 (7): 574-580. http://dx.doi.org/10.1136/thx.2003.019588
  11. Greening N.J., Evans R.A., Williams J.E. et al. Does body mass index influence the outcomes of a waking-based pulmonary rehabilitation programme in COPD? Chron. Respir. Dis. 2012; 9 (2): 99-106. http://dx.doi.org/10.1177/1479972312439317
  12. Hu G., Cassano P.A. Antioxidant nutrients and pulmonary function: the third national health and nutrition examination survey (NHANES III). Am. J. Epidemiol. 2000; 151 (10): 975-981. http://dx.doi.org/10.1093/oxfordjournals.aje.a010141
  13. Kolarzyk E., Kieć E., Gałuszka Z. et al. Effect of obesity on the ventilatory capacity of the respiratory system. II. Reference spirometry values of VC and FEV1 for overweight males. Med. Pr. 2005; 36 (3): 184-190.
  14. Koutsoukou A., Koulouris N., Bekos B. et al. Expiratory flow limitation in morbidly obese postoperative mechanically ventilated patients. Acta. Anaesthesiol. Scand. 2014; 48 (9): 1080-1088. http://dx.doi.org/10.1111/j.1399-6576.2004.00479.x
  15. Lainscak M., von Haehling S., Doehner W. et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of COPD. J. Cachexia Sarcopenia Muscle. 2011; 2 (2): 81-86. http://dx.doi.org/10.1007/s13539-011-0023-9
  16. Landbo C., Prescott E., Lange P. et al. Prognostic value of nutritional status in COPD. Am. J. Respir. Crit. Care Med. 2009; 160 (6): 1856-1861. http://dx.doi.org/10.1164/ajrccm.160.6.9902115
  17. Li A.M., Chan D., Wong E. et al. The effect of obesity on pulmonary function. Arch. Dis. Child. 2013; 88: 361-363. http://dx.doi.org/10.1136/adc.88.4.361
  18. Lehouck A., Mathieu C., Carremans C. et al. High doses of vitamin D to reduce exacerbations in COPD: randomized trial. Ann. Intern. Med. - 2012; 156 (2): 105-114. http://dx.doi.org/10.7326/0003-4819-156-2-201201170-00004
  19. Leone N., Courbon D., Thomas F. et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am. J. Respir. Crit. Care Med. 2009; 179 (6): 509-516. http://dx.doi.org/10.1164/rccm.200807-1195OC
  20. Marquis K., Maltais F., Duguay V. et al. The metabolic syndrome in patients with chronic obstructive pulmonary disease. J. Cardiopulm. Rehabil. 2011; 25 (4): 226-232. http://dx.doi.org/10.1097/00008483-200507000-00010
  21. McKeever T.M., Lewis S.A., Cassano P.A. et al. Patterns of dietary intake and relation to respiratory disease, forced expiratory volume in 1 s, and decline in 5-y forced expiratory volume. Am. J. Clin. Nutr. 2010; 92 (2): 408-415. http://dx.doi.org/10.3945/ajcn.2009.29021
  22. Miedema I., Feskens E.J., Heederik D., Kromhout D. Dietary determinants of long-term incidence of chronic nonspecific lung diseases. The Zutphen study. Am. J. Epidemiol. 2013; 138 (1): 37-45.
  23. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief. 2012; (82): 1-8.
  24. Paek Y.J., Jung K.S., Hwang Y.I. et al. Association between low pulmonary function and metabolic risk factors in Korean adults. Metabolism. 2010; 59 (9): 1300-1306. http://dx.doi.org/10.1016/j.metabol.2009.12.005
  25. Park S.K., Larson J.L. Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease. West J. Nurs. Res. 2014; 36 (5): 620-642. http://dx.doi.org/10.1177/0193945913512423
  26. Peeters A., Barendregt J.J., Willekens F. et al. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann. Intern. Med. 2013; 138 (1): 24-32. http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00008
  27. Pérez Rodrigo C. Current mapping of obesity. Nutr. Hosp. 2013; 28 (5): 21-31.
  28. Poulain M., Doucet M., Drapeau V. et al. Metabolic and inflammatory profile in obese patients with COPD. Chron. Respir. Dis. 2008; 5 (1): 35-41. http://dx.doi.org/10.1177/1479972307087205
  29. Rautalahti M., Virtamo J., Haukka J. et al. The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. Am. J. Respir. Crit. Care Med. 2007; 156 (5): 1447-1452. http://dx.doi.org/10.1164/ajrccm.156.5.96-11048
  30. Sabino P.G., Silva B.M., Brunetto A.F. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics (Sao Paulo). 2010; 65 (16): 599-605. http://dx.doi.org/10.1590/S1807-59322010000600007
  31. Shaheen S.O., Jameson K.A., Syddall H.E. et al. The relationship of dietary patterns with adult lung function and COPD. Eur. Respir. J. 2010; 36 (2): 277-284. http://dx.doi.org/10.1183/09031936.00114709
  32. Shields M., Carroll M.D., Ogden C.L. Adult obesity prevalence in Canada and the United States. NCHS Data Brief. 2011; (56): 1-8.
  33. Steuten L.M., Creutzberg E.C., Vrijhoef H.J., Wouters E.F. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim. Care Respir. J. 2011; 15 (2): 84-91. http://dx.doi.org/10.1016/j.pcrj.2005.09.001
  34. Ubilla C., Bustos P., Amigo H. et al. Nutritional status, especially body mass index, from birth to adulthood and lung function in young adulthood. Ann. Hum. Biol. 2008; 35 (3): 322-333. http://dx.doi.org/10.1080/03014460801978937
  35. Vozoris N.T., O’Donnell D.E. Prevalence, risk factors, activity limitation and health care utilization of an obese, population-based sample with COPD. Can. Respir. J. 2012; 19 (3): 18-24. http://dx.doi.org/10.1155/2012/732618
  36. World Health Organization. Obesity and overweight. 2013. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (access date: 06.12.2013).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

© 2016 Kozhevnikova S.A., Budnevskiy A.V., Malysh E.J., Ovsyannikov E.S.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies